comparemela.com

Latest Breaking News On - Sanofi healthcare india - Page 6 : comparemela.com

Sanofi receives approval for Dupixent in India for atopic dermatitis treatment

Sanofi receives approval for Dupixent in India for atopic dermatitis treatment
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

European unionSanofi healthcare indiaGeneral managerSanofi specialty care

ChrysCap-backed Corona Remedies buys Sanofi s muscle relaxant brand

Ahmedabad-based Corona Remedies, which counts private equity firm ChrysCapital as an investor, has bought drugmaker Sanofi Healthcare India's muscle relaxant brand Myoril for Rs 234 ..

Chandra pharmalabKirtibhai mehtaAnuj suvarnaAnkur mehtaNirav mehtaChryscap backed corona remediesCap backed corona remediesCorona remediesSanofi healthcare indiaSanofi consumer healthcareSanofi indiaSubscribe nowCorona remedies pvt ltdAnuj suvarnaM amp a

Sanofi to Reduce Workforce at Vaccine Plants in India

Sanofi failed to secure the UNICEF contract to supply Shan-5, a vaccine for a range of diseases including diphtheria, tetanus and hepatitis B

Andhra pradeshSanofi healthcare india pvt ltdWorld health organizationSanofi indiaReduce workforceVaccine plantsSanofi healthcare indiaWorld health

Panacea Biotec files suit before Delhi HC against Sanofi Healthcare

In matter related to patent for its fully liquid Whole Cell Pertussis based fully liquid Hexavalent Vaccine, EasySix™Panacea Biotec announced that the company has instituted a suit before the Hon ble Delhi High Court seeking to restrain Sanofi Healthcare India from marketing a fully liquid hexavalent vaccine that would infringe Company s patent for its fully liquid Whole Cell Pertussis based fully liquid Hexavalent Vaccine, EasySix™. Panacea Biotec s EasySix™ is a first of its kind Whole Cell Pertussis based fully liquid Hexavalent Vaccine which comes in a pre-filled syringe and is used to vaccinate against, Diphtheria, Tetanus, Whooping Cough, Hepatitis B, Haemophilus influenza type b and Inactivated Polio (DTwP-HepB-Hib-IPV). EasySix™ has been in the market since 2017.

Biotec easysixHonble delhi high courtWhole cell pertussisHexavalent vaccinePanacea biotecSanofi healthcare indiaWhooping coughInactivated polioDrugs controller generalDelhi high courtCapital marketMedical specialtiesWhooping coughClinical medicineHexavalent vaccinePentavalent vaccine

Nifty, Sensex may continue to rally – Monday closing report

Nifty, Sensex may continue to rally – Monday closing report Moneylife Digital Team 0 We had mentioned in previous week’s closing report that Nifty, Sensex may rally. On Monday, the indices opened rallied and closed with major gains. On the NSE, there were 1,333 advances, 627 declines and 339 unchanged. The trends of the major indices in the course of Monday’s trading are given in the table below: Bharti Airtel reported a net profit of Rs 759.2 crore against a loss of Rs 5,237 crore in the year-ago period. Total revenue came in at Rs 25,747 crore, up 17.6% YoY. Colgate Palmolive India reported net profit of Rs 314.66 crore for the Jan-Mar 2021 quarter compared to Rs 204 crore in the previous year. Revenue grew to Rs 1,289 crore from Rs 1,090 crore in the same period of the previous year.

Bharti airtelEli lillyNatco pharmaAlgalr nutrapharms privateMoneylife digital teamCamlin fine sciencesPalmolive indiaPumps indiaFederal bankSanofi healthcare indiaWhole cell pertussisHexavalent vaccineFine sciencesMutual fund returnsAnk fixed depositsNvestor returns

vimarsana © 2020. All Rights Reserved.